Indian Biotech Industry (2005)

Table of Contents

1. Biotechnology In India -An Introduction

2. Biotech Sector In India: Changing Legal Framework

• 2.1 Fiscal Incentives Provided To The Biotech Sector
• 2.2 Important Changes To The Patents Act Proposed In The Third Amendment Bill
• 2.3 Plant Varieties And Farmers' Rights Protection Act, 2001
• 2.4 Other Regulations Impacting The Biotech Sector
  • 2.4.1 Licensing
  • 2.4.2 Clinical Trials
  • 2.4.3 Seeds Act And Policy
  • 2.4.4 Environmental Clearances
  • 2.4.5 Biodiversity
• 2.5 Status On Enforcement

3. Bio-Clusters: State Driven Initiatives And Policies

• 3.1 Southern Region
• 3.2 Western Region
• 3.3 Northern Region

4. Indian Biotechnology Market Analysis, 2005

• 4.1 Total Market Size, (%) 2005
• 4.2 Growth Forecasts For The Indian Biotechnology Industry, ($ Millions) 2007-2010
• 4.3 Market Size By Industry Segments, (%) 2005
  • 4.3.1 Biopharmaceuticals
  • 4.3.2 Bioinformatics
  • 4.3.3 Industrial Biotech
  • 4.3.4 Agri Biotech
  • 4.3.5 Bioservices (Contract Research)
  • 4.3.6 Employment In Indian Biotech Industry, (%)
• 4.4 Biotech Exports, By Segment-Wise, (%) 2005
  • 4.4.1 Biotech Suppliers
• 4.5 Number Of Companies And Associations, (In Numbers) 2005
• 4.6 Employment Opportunities In India
• 4.7 Investments In Indian Biotechnology Sector, 2005
• 4.8 Status Of Biotech Parks In India

5. Swot Analysis Of Indian Biotechnology Sector

6. India Biotechnology Industry And Outsourcing Opportunities

7. India's Biotechnology Research And Development Strengths

8. India's New Draft National Biotechnology Development Strategy- Geared Towards Encouraging Public-Private Partnership

9. Key Industry Trends And Opportunities In Indian Biotech Industry

10. Strategies For The Indian Biotech Industry Future

• 10.1 Generate National Level Resource Strength In Bioinformatics
• 10.2 Promote R& D Strengths
• 10.3 Promote Entrepreneurial Development
• 10.4 Globalization Of The National Bioinformatics Initiatives
• 10.5 Encourage Human Resource Development, Education, & Awareness
• 10.6 Restructuring Of The Btis Organization For Optimized Performance

11. Financial Strategy For Emerging Bio-Companies

12. Company Profiles Of Key Players

• 12.1 Biocon
• 12.2 Serum Institute Of India
• 12.3 Panacea Biotech
• 12.4 Nicholas Piramal
• 12.5 Wockhardt Limited
• 12.6 Glaxosmithkline
• 12.7 Bharat Serums
• 12.8 Krebs Biochemical's & Industries Limited
• 12.9 Indian Immunologicals
• 12.10 Zydus Cadila
• 12.11 Shantha Biotechnics
• 12.12 Biological E
• 12.13 Chiron Behring Vaccines
• 12.14 Eli Lilly And Company
• 12.15 Novo Nordisk
• 12.16 Mahyco Monsanto
• 12.17 Bharat Biotech
• 12.18 Abbott
• 12.19 Ranbaxy
• 12.20 Novozymes